Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart attack recovery: do women and men get equal prevention care?

NCT ID NCT05619601

Knowledge-focused Sponsor: Spanish Society of Cardiology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 530 heart attack survivors from 25 Spanish hospitals to see if women and men differ in how well they follow prevention advice, like taking medications, eating healthy, exercising, and joining rehab programs. Researchers matched women and men by age and heart attack type and followed them for one year. The goal is to find any gender gaps in prevention adherence and understand why they happen.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could reveal why women and men may need different support after a heart attack to stick with prevention plans.
What could go wrong
This is an observational study, not a treatment test. It can show differences but not prove what causes them or how to fix them.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

530 people

The number who actually took part.

Started

Mar 2023

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Prospective, matched cohort study of patients hospitalized for a type 1 AMI with evidence of obstructive coronary artery disease who are discharged home alive. Women will be enrolled first, ideally in a consecutive manner, as they are the focus of the study. Men will be recruited subsequently as the comparison group, with 1:1 matching for age and ECG presentation. Matching will be performed locally, in each study site (hospital). All patients will undergo 1-year follow-up with clinical and therapeutic adherence evaluation. Reference cohort: 500 women discharged alive after a hospitalization for a type 1 AMI with significant CAD. Comparator cohort: 500 age (±2 years) and ECG (STEMI/NSTEMI) locally matched men discharged alive after a hospitalization for a type 1 AMI with significant CAD.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hospitalization for a type 1 acute myocardial infarction (detection of a rise and/or fall of troponin c value above the 99th percentile upper reference limit (URL) and with at least one of the followings: symptoms of acute myocardial ischemia; new ischaemic ECG changes; development of pathological Q waves; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality in a patterns consistent with an ischaemic aetiology; identification of a coronary thrombus by angiography including intracoronary imaging) * Presence of obstructive coronary artery disease (CAD) (i.e. coronary artery stenosis ≥50%) * Age \>18 years. No maximal age limit applies * Signed informed consent Exclusion Criteria: * Terminal disease (expected survival \<12 months) * Unavailable for 12-month follow-up (i.e.: living abroad, social situation…) * Does not speak Spanish * Major active comorbidity (severe renal or liver failure, active cancer requiring chemotherapy…), interfering with regular post-myocardial infarction management

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, medication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute myocardial infarction Coitus Medication Adherence Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, medication Gender differences Therapeutic adherence Type 1 acute myocardial infarction

Contacts and locations

Locations

  • Complejo Asistencial Universitario de León

    León, León, Spain

  • Complejo Hospitalario Universitario de Albacete

    Albacete, Albacete, Spain

  • Complejo Hospitalario Universitario de Canarias, La Laguna

    San Cristóbal de La Laguna, Tenerife, Spain

  • Complejo Hospitalario de Navarra

    Pamplona, Navarre, Spain

  • Complejo Hospitalario de Toledo

    Toledo, Toledo, Spain

  • Hospital Clínico Universitario Lozano Blesa

    Zaragoza, Zaragoza, Spain

  • Hospital Clínico Universitario de Salamanca

    Salamanca, Salamanca, Spain

  • Hospital Clínico Universitario de Valencia

    Valencia, Valencia, Spain

  • Hospital General Universitario de Alicante

    Alicante, Alicante, Spain

  • Hospital San Pedro de Alcántara

    Cáceres, Cáceres, Spain

  • Hospital Universitari Son Espases, Palma de Mallorca

    Palma de Mallorca, Balearic Islands, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Madrid, Spain

  • Hospital Universitario Central de Asturias

    Oviedo, Principality of Asturias, Spain

  • Hospital Universitario Fundación Alcorcón

    Alcorcón, Madrid, Spain

  • Hospital Universitario Marqués de Valdecilla

    Santander, Cantabria, Spain

  • Hospital Universitario Vall´d Hebron

    Barcelona, Barcelona, Spain

  • Hospital Universitario Virgen Macarena

    Seville, Sevilla, Spain

  • Hospital Universitario Virgen de la Arrixaca

    Murcia, Murcia, Spain

  • Hospital Universitario Virgen de la Victoria

    Málaga, Málaga, Spain

  • Hospital Universitario de Basurto

    Bilbao, Vizcaya, Spain

  • Hospital Universitario de Bellvitge

    Barcelona, Barcelona, Spain

  • Hospital Universitario de Gran Canaria Dr. Negrín

    Las Palmas de Gran Canaria, Las Palmas, Spain

  • Hospital Universitario de Santiago de Compostela

    Santiago de Compostela, A Coruña, Spain

  • Hospital Universitario de Áraba/Txagorritxu

    Vitoria-Gasteiz, Vitoria, Spain

  • Hospital Álvaro Cunqueiro de Vigo

    Vigo, Pontevedra, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.